Logo
ScienceStack
Table of Contents
Fetching ...
Sign In

A Bayesian Discrete Framework for Enhancing Decision-Making Processes in Clinical Trial Designs and Evaluations

Paramahansa Pramanik, Arnab Kumar Maity, Anjan Mandal, Haley Kate Robinson

TL;DR

This study examines the application of Bayesian approach in the context of clinical trials, emphasizing their increasing importance in contemporary biomedical research and considers persistent challenges in clinical investigations, including replication difficulties and the misinterpretation of statistical results.

Abstract

This study examines the application of Bayesian approach in the context of clinical trials, emphasizing their increasing importance in contemporary biomedical research. While conventional frequentist approach provides a foundational basis for analysis, it often lacks the flexibility to integrate prior knowledge, which can constrain its effectiveness in adaptive settings. In contrast, Bayesian methods enable continual refinement of statistical inferences through the assimilation of accumulating evidence, thereby supporting more informed decision-making and improving the reliability of trial findings. This paper also considers persistent challenges in clinical investigations, including replication difficulties and the misinterpretation of statistical results, suggesting that Bayesian strategies may offer a path toward enhanced analytical robustness. Moreover, discrete probability models, specifically the Binomial, Poisson, and Negative Binomial distributions are explored for their suitability in modeling clinical endpoints, particularly in trials involving binary responses or data with overdispersion. The discussion further incorporates Bayesian networks and Bayesian estimation techniques, with a comparative evaluation against maximum likelihood estimation to elucidate differences in inferential behavior and practical implementation.

A Bayesian Discrete Framework for Enhancing Decision-Making Processes in Clinical Trial Designs and Evaluations

TL;DR

This study examines the application of Bayesian approach in the context of clinical trials, emphasizing their increasing importance in contemporary biomedical research and considers persistent challenges in clinical investigations, including replication difficulties and the misinterpretation of statistical results.

Abstract

This study examines the application of Bayesian approach in the context of clinical trials, emphasizing their increasing importance in contemporary biomedical research. While conventional frequentist approach provides a foundational basis for analysis, it often lacks the flexibility to integrate prior knowledge, which can constrain its effectiveness in adaptive settings. In contrast, Bayesian methods enable continual refinement of statistical inferences through the assimilation of accumulating evidence, thereby supporting more informed decision-making and improving the reliability of trial findings. This paper also considers persistent challenges in clinical investigations, including replication difficulties and the misinterpretation of statistical results, suggesting that Bayesian strategies may offer a path toward enhanced analytical robustness. Moreover, discrete probability models, specifically the Binomial, Poisson, and Negative Binomial distributions are explored for their suitability in modeling clinical endpoints, particularly in trials involving binary responses or data with overdispersion. The discussion further incorporates Bayesian networks and Bayesian estimation techniques, with a comparative evaluation against maximum likelihood estimation to elucidate differences in inferential behavior and practical implementation.
Paper Structure (15 sections, 33 equations, 5 figures, 4 tables)

This paper contains 15 sections, 33 equations, 5 figures, 4 tables.

Table of Contents

  1. Abstract.
  2. Key words:
  3. Introduction.
  4. Preliminaries.
  5. Uniform Distribution.
  6. Binomial Distribution.
  7. Poisson Distribution.
  8. Negative Binomial Distribution.
  9. Conditional Probability.
  10. Bayes Theorem.
  11. Bayes Factor.
  12. Bayes Factors and $p$-values.
  13. Bayes Theorem in Discrete Distributions.
  14. Bayesian Estimation and Maximum Likelihood Estimation.
  15. Conclusion.

Figures (5)

  • Figure 1: Bayesian Network with 100 HIV patients (Directed Acyclic Graph ).
  • Figure 2: Bayesian Network with 500 HIV patients DAG.
  • Figure 3: Estimated HIV test result probabilities converge to a uniform distribution as prior strength increases, illustrating the diminishing influence of risk classification under strong prior assumptions.
  • Figure 4: Updating Beliefs with Bayes Factor: Prior vs Posterior Probabilities of HIV Status.
  • Figure 5: The Bayes rule.